This ETF is trying to satisfy appetites for weight loss stocks
Tema ETFs is behind the GLP-1, Obesity & Cardiometabolic ETF (HRTS), which is up 26% since its inception last November.
Read MoreTema ETFs is behind the GLP-1, Obesity & Cardiometabolic ETF (HRTS), which is up 26% since its inception last November.
Read MoreNvidia is a fan of Recursion Pharmaceuticals. Data expected from the company will help determine valuations for stocks using AI
Read MoreNovo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye
Read MoreIt's a long-awaited win for Eli Lilly after donanemab faced several delays in its path to the market, including an
Read MoreFarmer Yigit Aksel stares into a sinkhole in fields near Karapinar in central Turkey. Every time Turkish farmer Fatih Sik
Read MoreBoeing's crew flight test represents the first time Starliner is carrying people, flying NASA astronauts Butch Wilmore and Suni Williams. Source
Read MoreDrugmakers showed off data on weight loss and diabetes drugs. Also, Oracle announced the general availability of AI documentation assistant
Read MoreChina's Chang'e-6 lunar probe returned to Earth on Tuesday, bringing back the first-ever samples from the far side of the
Read MoreISTANBUL China on Saturday launched an astronomical satellite developed with France to capture bursts of high-energy gamma rays from distant
Read More